Per Eystein Lønning
Haukeland University Hospital · 640 works · 59,102 citations · h-index 74
Top works
- Molecular portraits of human breast tumours
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- Repeated observation of breast tumor subtypes in independent gene expression data sets
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
- Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
- Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
- Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
- Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays
- Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer
- Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
- Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study
- Mutation of GATA3 in human breast tumors
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
- Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer
- Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial
- Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation